Alcohol-Associated Liver Disease: Evolving Concepts and Treatments David Stephen PrinceEmily NashKen Liu Leading Article Open access 25 September 2023 Pages: 1459 - 1474
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy Arun RajasekaranTodd J. GreenDana V. Rizk Review Article 25 September 2023 Pages: 1475 - 1499
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review Robert Terkeltaub Review Article 11 October 2023 Pages: 1501 - 1521
Continued Opioid Use and Adverse Events Following Provision of Opioids for Musculoskeletal Pain in the Emergency Department: A Systematic Review and Meta-Analysis Qiuzhe ChenChris G. MaherGustavo C. Machado Systematic Review Open access 28 September 2023 Pages: 1523 - 1535
Lotilaner Ophthalmic Solution 0.25%: First Approval Yahiya Y. Syed AdisInsight Report Open access 16 October 2023 Pages: 1537 - 1541
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval Yahiya Y. Syed Correction Open access 31 October 2023 Pages: 1543 - 1543
Correction to: Rozanolixizumab: First Approval Sheridan M. Hoy Correction Open access 20 October 2023 Pages: 1569 - 1569
